182 related articles for article (PubMed ID: 36070542)
1. Community Perspective on Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
Borowitz D; Brooks JF; Aliaj E; Gallotto D
J Pediatr Gastroenterol Nutr; 2022 Nov; 75(5):e94-e97. PubMed ID: 36070542
[TBL] [Abstract][Full Text] [Related]
2. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
Boon M; Calvo-Lerma J; Claes I; Havermans T; Asseiceira I; Bulfamante A; Garriga M; Masip E; van Schijndel BAM; Fornes V; Barreto C; Colombo C; Crespo P; Vicente S; Janssens H; Hulst J; Witters P; Nobili R; Pereira L; Ruperto M; Van der Wiel E; Mainz JG; De Boeck K; Ribes-Koninckx C
J Cyst Fibros; 2020 Jul; 19(4):562-568. PubMed ID: 32335023
[TBL] [Abstract][Full Text] [Related]
3. Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.
Ng C; Major G; Smyth AR
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013488. PubMed ID: 34339047
[TBL] [Abstract][Full Text] [Related]
4. Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Olsen MF; Kjøller-Svarre MS; Møller G; Katzenstein TL; Nielsen BU; Pressler T; Lewis JI; Mathiesen IH; Mølgaard C; Faurholt-Jepsen D
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405943
[TBL] [Abstract][Full Text] [Related]
5. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Woestenenk JW; van der Ent CK; Houwen RH
J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
Freswick PN; Reid EK; Mascarenhas MR
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405954
[TBL] [Abstract][Full Text] [Related]
8. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.
Hayee B; Watson KL; Campbell S; Simpson A; Farrell E; Hutchings P; Macedo P; Perrin F; Whelan K; Elston C
United European Gastroenterol J; 2019 Aug; 7(7):881-888. PubMed ID: 31428412
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
11. Impact of timing of PERT on gastrointestinal symptoms in Danish children and adolescents with CF.
Raun AMT; Brekke G; Mølgaard C; Jaudszus A; Mainz JG; Pressler T; Skov M
Acta Paediatr; 2022 Feb; 111(2):432-439. PubMed ID: 34626004
[TBL] [Abstract][Full Text] [Related]
12. Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard?
Borowitz D; Aronoff N; Cummings LC; Maqbool A; Mulberg AE
Pancreas; 2022 Apr; 51(4):310-318. PubMed ID: 35695742
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy.
McDonald CM; Reid EK; Pohl JF; Yuzyuk TK; Padula LM; Vavrina K; Altman K
Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S57-S77. PubMed ID: 38429959
[TBL] [Abstract][Full Text] [Related]
14. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
[TBL] [Abstract][Full Text] [Related]
15. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju URR; Solis-Moya A
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008227. PubMed ID: 32761612
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis.
Calvo-Lerma J; Boon M; Colombo C; de Koning B; Asseiceira I; Garriga M; Roca M; Claes I; Bulfamante A; Walet S; Pereira L; Ruperto M; Masip E; Asensio-Grau A; Giana A; Affourtit P; Heredia A; Vicente S; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
J Cyst Fibros; 2021 Sep; 20(5):e33-e39. PubMed ID: 33279468
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Absorption of Lipids Using a Pancreatic Enzyme-Free Nutritional Supplement in Patients with Cystic Fibrosis: A Randomized, Double-Blind, Crossover Pilot Trial.
Barto TL; Morency CF; Schaap N; Patel AB; Monticello DJ
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277038
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.
Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D;
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494
[TBL] [Abstract][Full Text] [Related]
20. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
Borowitz D; Stevens C; Brettman LR; Campion M; Chatfield B; Cipolli M;
J Cyst Fibros; 2011 Dec; 10(6):443-52. PubMed ID: 21831726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
